Pfizer Animal Health

Get more information about a specific species.


Wound Care



Wounds - whether accidental (caused by cars, other animals, sharp objects, gunshots, blunt impact or falling) or intentional (ear cropping, tail docking, surgery) - can result in pain, bleeding, infection and loss of function. Basic wound management includes:
  • control of bleeding

  • removal of debris and tissue debridement

  • drainage

  • promotion of vascularization

  • wound closure
Unattended wounds are an ideal breeding ground for infection.



Aerobic Infections

A common aerobic pathogen, Staphylococcus intermedius, is implicated in many infected wounds. Staphylococcus aureus is sometimes isolated as well. Gaining entry through broken skin or mucous membranes, the cocci begin to multiply. Tissue trauma often produces ischemia, reduced or obstructed blood supply, which shields the bacteria from the host's immune system and favors continued growth. Certain staphylococci also produce enzymes and toxins that accelerate the death, or necrosis, of surrounding cells and tissue. Some strains encapsulate themselves, creating a physical barrier between the infection and the body's defenses.

The typical staph infection produces inflammation, necrosis and pus-filled abscesses. If staphylococci enter the bloodstream, they readily invade almost any tissue and organ in the body, including bone. Osteomyelitis (infection of the bone and associated tissues), pyoderma (pus-associated skin infection), and pyometra (pus in the uterus) can all be caused by staphylococci.

Effective treatment of staphylococcal infections often starts with surgical drainage of the pus and cleansing of the wound. Antibiotic therapy requires a drug active against staphylococci and one that penetrates beyond the body's circulation to the site of infection.



Anaerobic Infections

The body's normal bacterial population (flora) is predominantly anaerobic. Obligate anaerobes colonize virtually every mucous membrane surface of the body. In the mouth, for example, obligate and facultative anaerobes outnumber other bacteria 10 to 1. Anaerobes survive in the mouth because oral streptococci lower the oxidation-reduction, or redox potential, creating a welcoming environment. Such bacterial synergy is important in the pathogenesis of anaerobic infections.


How Infections Start

Most anaerobic infections begin with a break in the skin or mucous membranes that permits normally present bacteria to invade underlying tissues. Strict aerobes and facultative anaerobes deplete the available oxygen, creating the ideal environment for obligate anaerobes. Most anaerobic infections are polymicrobial or mixed, containing both obligate and facultative anaerobes. Mixed infections often progress through several stages as the bacterial populations shift in accordance with the changing microenvironment.

The virulence of anaerobic infections increases if the bacteria produce enzymes or toxins capable of destroying surrounding tissue. Common veterinary pathogens - including Bacteroides and Clostridium perfringens - all release enzymes or toxins. Dense bacterial populations within abscesses often manufacture beta-lactamase, which can inactivate cephalosporins and penicillins.

Bacterial synergy also increases the virulence of anaerobic infections. In a mixed infection, Bacteroides melaninogenicus sometimes protects nearby bacteria by inhibiting the body's immune system response. And nonpathogenic streptococci produce the vitamin K, required by Bacteroides melaninogenicus for continued growth.



Clinically Important Anaerobes

In a survey of veterinary pathogens, the most common anaerobes (in decreasing order of frequency) were:
  • Bacteroides

  • Clostridium

  • Propionibacterium

  • Actinomyces

  • Peptostreptococcus

  • Peptococcus
Anaerobes typically thrive in the nose, mouth, and digestive and reproductive tracts.



Clues to Anaerobic Infections

Suspect anaerobic infections when:
  • foul-smelling discharge is present

  • standard culture techniques produce no microbial growth from abscess samples

  • infection sets in after surgery

  • abdominal trauma or sepsis involves penetration of mucosal surfaces

  • deep abscesses, infection of malignant tumors, or pyometra occur

  • infections do not respond to conventional antibiotic therapy
Anaerobic infections typically smell foul, produce little or no swelling, spread along tissue planes, and result in necrosis.



Anaerobes in Clinical Syndromes

Because anaerobes are difficult to culture in the laboratory, they may be overlooked in treatment decisions. However, these clinical syndromes frequently involve anaerobes.
  • Periodontal disease and bacterial endocarditis from dental manipulations - Bacteroides is consistently present in gingivitis. Peptostreptococcus is also common.

  • Lung infection resulting from aspiration pneumonia - Bacteroides and Peptostreptococcus are frequently found

  • Postsurgical infection

  • Bacteremia and intra-abdominal sepsis

  • Gynecologic infections, usually due to Bacteroides

  • Central nervous system infection or cerebral abscesses




Treatment Considerations

Preliminary diagnosis of an anaerobic infection is usually based on clinical clues, because culturing anaerobes is a difficult and time-consuming process. Successful treatment of anaerobic infections almost always begins with drainage and debridement, strategies that restore normal circulation and tissue oxygenation. Antimicrobial therapy aims to eradicate anaerobic pathogens and prevent their spread to adjacent tissues. If necrotic tissue remains or antimicrobial therapy is inappropriate, the infection is sure to recur.

Several factors influence the choice of an appropriate antimicrobial. Among them:
  • The polymicrobial nature of anaerobic infections. The additive effect of toxins and enzymes can increase the severity of the infection, and production of beta-lactamase by one bacterium species can protect the entire microbial population.

  • The consistent presence of Bacteroides, some strains of which are resistant to penicillins, cephalosporins and tetracycline.

  • The frequent failure of beta-lactamase antibiotics. Beta-lactamase inhibitors sometimes fail because:
    • bacteria produce sufficient beta-lactamase to overwhelm them
    • exposure to beta-lactams stimulates some bacteria to produce large amounts of beta-lactamase
    • beta-lactamase inhibitors can't stop all beta-lactamase production



Antibiotic Options

For more information on antibiotic options, please visit the ANTIROBE® AQUADROPS® (clindamycin hydrochloride) Liquid, CLAVAMOX® (amoxicillin trihydrate, clavulanate potassium) Drops, and ZENIQUIN® (marbofloxacin) Tablets overviews.

When ANTIROBE was tested in clinical trials, vomiting and diarrhea were occasionally observed.

CLAVAMOX is contraindicated for use in animals with a history of allergic reaction to any of the penicillins or cephalosporins. Safety of use in pregnant or breeding animals has not been determined.

ZENIQUIN, as with all fluoroquinolones, is not recommended for use in immature cats during the rapid growth phase, or in cats known to be hypersensitive to fluoroquinolones. The most common adverse reactions observed during clinical studies were decreased activity, loss of appetite, vomiting and diarrhea.

 entire article (printer friendly)

Pet Health Topics

Select a topic below to view more information.

View all Cat topics

= Technical Information

Locate a Product

Use the menus below to find product information.

 View all PfizerAH Cats products

Locate a Product

There are no scheduled
events listed at this time.

Search
 
Advanced Search




Copyright © 2010 Pfizer Inc. All rights reserved.


The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider, considering the unique characteristics of the patient.